Metacrine, Inc. Contracts & Agreements
35 Contracts & Agreements
- Business Finance (10 contracts)
- Human Resources (16)
- Intellectual Property (1)
- Mergers & Acquisitions (1)
- Real Estate (2)
- Uncategorized (5)
- Plan of Dissolution of Metacrine, Inc (Filed With SEC on January 24, 2023)
- Separation Agreement and General Release of All Claims, dated as of January 24, 2023, by and between Metacrine, Inc. and Preston Klassen (Filed With SEC on January 24, 2023)
- Agreement and Plan of Merger, dated September 6, 2022, by and among Equillium, Inc., Metacrine, Inc., Equillium Acquisition Sub, Inc., and Triumph Merger Sub, Inc (Filed With SEC on September 6, 2022)
- Consulting Agreement, dated January 7, 2022, by and between the Registrant and Hubert Chen (Filed With SEC on May 12, 2022)
- Employment Agreement dated November 2, 2021 by and between the Company and Michael York (Filed With SEC on March 30, 2022)
- Transition, Separation and Consulting Agreement, dated as of March 2, 2022, by and between the Company and Patricia Millican (Filed With SEC on March 30, 2022)
- Agreement for Termination of Lease and Voluntary Surrender of Premises, dated as of March 11, 2022, by and between Metacrine, Inc. and ARE-SD Region No. 30, LLC (Filed With SEC on March 15, 2022)
- Warrant to Purchase Common Stock, dated October 1, 2021, issued to K2 HealthVentures Equity Trust LLC (Filed With SEC on November 12, 2021)
- Second Amendment to Loan and Security Agreement, dated October 1, 2021, by and between the Registrant and K2 HealthVentures LLC and any other lender from time to time party... (Filed With SEC on November 12, 2021)
- Metacrine, Inc. Non-Employee Director Compensation Policy, As Amended on May 24, 2021 (Filed With SEC on August 12, 2021)
- Metacrine, Inc. 2020 Equity Incentive Plan Forms of RSU Award Grant Notice and RSU Award Agreement (Filed With SEC on August 12, 2021)
- Amended and Restated Consulting Agreement by and between the Registrant and Jeff Jonker dated March 10, 2021 (Filed With SEC on May 13, 2021)
- Description of Capital Stock of the Registrant (Filed With SEC on March 18, 2021)
- Offer Letter by and between the Registrant and Catherine Lee (Filed With SEC on March 18, 2021)
- Form of Underwriting Agreement (Filed With SEC on September 9, 2020)
- Form of Common Stock Certificate of the Registrant (Filed With SEC on September 9, 2020)
- Metacrine, Inc. 2020 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on September 9, 2020)
- Metacrine, Inc. 2020 Employee Stock Purchase Plan (Filed With SEC on September 9, 2020)
- Metacrine, Inc. Non-Employee Director Compensation Policy (Filed With SEC on September 9, 2020)
- Amended and Restated Investor Rights Agreement, dated August 26, 2019, by and among the Registrant and certain of its stockholders (Filed With SEC on August 24, 2020)
- Warrant to Purchase Preferred Stock, dated August 27, 2019, issued to K2 HealthVentures Equity Trust LLC (Filed With SEC on August 24, 2020)
- Form of Indemnity Agreement by and between the Registrant and its directors and officers (Filed With SEC on August 24, 2020)
- Metacrine, Inc. Amended and Restated 2015 Equity Incentive Plan and Forms of Option Grant Notice, Option Agreement and Notice of Exercise thereunder, as amended (Filed With SEC on August 24, 2020)
- Metacrine, Inc. 2020 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on August 24, 2020)
- Metacrine, Inc. 2020 Employee Stock Purchase Plan (Filed With SEC on August 24, 2020)
- Metacrine, Inc. Non-Employee Director Compensation Policy (Filed With SEC on August 24, 2020)
- Metacrine, Inc. Severance Benefit Plan (Filed With SEC on August 24, 2020)
- Lease Agreement, dated June 16, 2017, by and between the Registrant and ARE-SD Region No. 30, LLC (Filed With SEC on August 24, 2020)
- Employment Agreement by and between the Registrant and Preston Klassen (Filed With SEC on August 24, 2020)
- Employment Agreement by and between the Registrant and Ken Song (Filed With SEC on August 24, 2020)
- Separation and Consulting Agreement by and between the Registrant and Ken Song (Filed With SEC on August 24, 2020)
- Offer Letter by and between the Registrant and Patricia Millican (Filed With SEC on August 24, 2020)
- Offer Letter by and between the Registrant and Hubert Chen (Filed With SEC on August 24, 2020)
- Amended and Restated Exclusive FXR License Agreement, dated November 10, 2016, by and between the Registrant and The Salk Institute for Biological Studies, as amended (Filed With SEC on August 24, 2020)
- Loan and Security Agreement, dated August 27, 2019, by and between the Registrant and K2 HealthVentures LLC and any other lender from time to time party thereto, K2 HealthVentures... (Filed With SEC on August 24, 2020)
